These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 35205966)

  • 1. Conventional Antifungals for Invasive Infections Delivered by Unconventional Methods; Aerosols, Irrigants, Directed Injections and Impregnated Cement.
    Drew RH; Perfect JR
    J Fungi (Basel); 2022 Feb; 8(2):. PubMed ID: 35205966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel modes of antifungal drug administration.
    Arthur RR; Drew RH; Perfect JR
    Expert Opin Investig Drugs; 2004 Aug; 13(8):903-32. PubMed ID: 15268632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosol and other novel administrations for prevention and treatment of invasive aspergillosis.
    Drew RH
    Med Mycol; 2009; 47 Suppl 1():S355-61. PubMed ID: 18654913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis.
    Beyer J; Schwartz S; Barzen G; Risse G; Dullenkopf K; Weyer C; Siegert W
    Infection; 1994; 22(2):143-8. PubMed ID: 8070928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspiring Antifungals: Review of Current Antifungal Pipeline Developments.
    Gintjee TJ; Donnelley MA; Thompson GR
    J Fungi (Basel); 2020 Feb; 6(1):. PubMed ID: 32106450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the epidemiology, prevention, diagnosis, and treatment of fungal pneumonia.
    Pound MW; Drew RH; Perfect JR
    Curr Opin Infect Dis; 2002 Apr; 15(2):183-94. PubMed ID: 11964921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphotericin B formulations: a comparative review of efficacy and toxicity.
    Hamill RJ
    Drugs; 2013 Jun; 73(9):919-34. PubMed ID: 23729001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of Histoplasma capsulatum variety capsulatum septic arthritis successfully treated with surgery, systemic antifungals, and local amphotericin cement beads.
    Compton J; Vander Voort W; Willey M; Sekar P
    Int J Infect Dis; 2018 Dec; 77():23-25. PubMed ID: 30273649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of antifungal agents using bioactive and nonbioactive bone cements.
    Sealy PI; Nguyen C; Tucci M; Benghuzzi H; Cleary JD
    Ann Pharmacother; 2009 Oct; 43(10):1606-15. PubMed ID: 19755620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective Management Of Topical Nosocomial Aspergillus Spp. Infections In Three Severely Burned Patients.
    Pantet O; Laurent A; Abdel-Sayed P; Hirt-Burri N; Michetti M; Raffoul W; Monod M; Applegate LA; de Buys Roessingh AS
    Ann Burns Fire Disasters; 2021 Sep; 34(3):235-239. PubMed ID: 34744538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphotericin B-impregnated bone cement to treat refractory coccidioidal osteomyelitis.
    Zhu ES; Thompson GR; Kreulen C; Giza E
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6341-3. PubMed ID: 24002101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on antifungal treatment of invasive Candida and Aspergillus infections.
    Maschmeyer G; Ruhnke M
    Mycoses; 2004 Aug; 47(7):263-76. PubMed ID: 15310328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of the Novel Investigational Antifungal Olorofim.
    Wiederhold NP
    J Fungi (Basel); 2020 Jul; 6(3):. PubMed ID: 32751765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of aerosolized amphotericin B formulations in the prevention and adjunctive treatment of invasive fungal infections.
    Drew R
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():36-44. PubMed ID: 16713192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isavuconazole: A New Option for the Management of Invasive Fungal Infections.
    Pettit NN; Carver PL
    Ann Pharmacother; 2015 Jul; 49(7):825-42. PubMed ID: 25940222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of treatment options for invasive fungal infections.
    Pound MW; Townsend ML; Dimondi V; Wilson D; Drew RH
    Med Mycol; 2011 Aug; 49(6):561-80. PubMed ID: 21366509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspofungin: first approved agent in a new class of antifungals.
    Johnson MD; Perfect JR
    Expert Opin Pharmacother; 2003 May; 4(5):807-23. PubMed ID: 12740003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
    Luu Tran H; Mahmoudjafari Z; Rockey M; Henry D; Grauer D; Aljitawi O; Abhyankar S; Ganguly S; Lin T; McGuirk J
    J Oncol Pharm Pract; 2016 Apr; 22(2):228-34. PubMed ID: 25471252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients.
    Drew RH; Dodds Ashley E; Benjamin DK; Duane Davis R; Palmer SM; Perfect JR
    Transplantation; 2004 Jan; 77(2):232-7. PubMed ID: 14742987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.